What causes sbp in cirrhosis

Overview

Spontaneous bacterial peritonitis (SBP) is a severe and potentially life-threatening complication that occurs in patients with advanced liver disease, particularly cirrhosis, accompanied by ascites (the accumulation of fluid in the abdominal cavity). It is defined as an infection of the ascitic fluid without any apparent intra-abdominal source of infection, such as a perforated viscus or an abscess. The condition arises from the migration of bacteria from the gastrointestinal tract into the bloodstream and subsequently into the ascitic fluid. This process is facilitated by a cascade of events that compromise the body's natural defenses.

What is Cirrhosis and Ascites?

Cirrhosis is the late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcoholism. The scarring can permanently damage the liver, leading to its inability to function properly. Ascites is a common complication of cirrhosis, occurring in more than 50% of patients with decompensated cirrhosis. It is characterized by the buildup of fluid in the peritoneal cavity, the space within the abdomen that contains the intestines, stomach, and liver. Ascites can cause abdominal distension, discomfort, shortness of breath, and an increased risk of infection.

Understanding Spontaneous Bacterial Peritonitis (SBP)

SBP is a specific type of infection that targets the ascitic fluid. It is considered 'spontaneous' because it develops without an obvious external cause or preceding surgical procedure. The infection occurs when bacteria, typically originating from the gut, cross the intestinal wall (translocation) and enter the bloodstream. From the bloodstream, these bacteria can then seed the ascitic fluid, leading to peritonitis. The incidence of SBP in patients with cirrhosis and ascites varies, but it is estimated to occur in up to 30% of hospitalized patients with ascites.

The Pathophysiology: How Does SBP Occur?

The development of SBP in cirrhosis is a multifactorial process involving several key mechanisms:

1. Bacterial Translocation

In healthy individuals, the intestinal barrier is robust, preventing bacteria and their products from entering the bloodstream. However, in cirrhosis, several factors weaken this barrier:

• Increased Intestinal Permeability: Liver dysfunction leads to impaired bile acid synthesis and reduced intestinal motility, which can alter the gut microbiota and increase the permeability of the intestinal wall. This allows bacteria and their toxins (like endotoxins) to leak from the gut lumen into the portal circulation.
• Portal Hypertension: Cirrhosis causes increased pressure in the portal vein, which carries blood from the digestive organs to the liver. This elevated pressure can lead to the formation of collateral blood vessels, bypassing the liver and allowing bacteria and toxins to enter the systemic circulation more easily.
• Impaired Immune Function: The liver plays a crucial role in the immune system, filtering bacteria and producing immune factors. In cirrhosis, the liver's ability to clear bacteria from the portal blood is significantly reduced. Furthermore, systemic immune cells, such as macrophages and neutrophils, may have impaired function, making it harder to fight off infections.

2. Low Ascitic Fluid Protein Content

Ascitic fluid in patients with cirrhosis often has a low concentration of protein, particularly less than 1.5 g/dL. Proteins like immunoglobulins and complement components in the ascitic fluid normally help to opsonize (tag) bacteria, making them easier for immune cells to engulf and destroy. A low protein content diminishes this protective effect, creating a more favorable environment for bacterial growth and survival within the ascites.

3. Bacterial Overgrowth in the Gut

Changes in gut motility, reduced stomach acid production, and altered bile salt metabolism in cirrhosis can lead to an overgrowth of bacteria in the small intestine (small intestinal bacterial overgrowth or SIBO). This overgrowth increases the bacterial load available for translocation across the intestinal barrier.

Common Causative Organisms

The majority of SBP cases are caused by Gram-negative aerobic bacteria, which are normally found in the gut. The most frequent culprits include:

• Escherichia coli (E. coli): Responsible for about 50-60% of SBP cases.
• Klebsiella pneumoniae: Another common Gram-negative bacterium.
• Other Gram-negative bacteria like Enterobacter species.
• Less commonly, Gram-positive bacteria such as Streptococcus pneumoniae and Staphylococcus species can also cause SBP, especially in patients who have received prior antibiotic prophylaxis.

Risk Factors for Developing SBP

While any patient with cirrhosis and ascites is at risk, certain factors significantly increase the likelihood of developing SBP:

• Severity of Liver Disease: Patients with advanced cirrhosis, as indicated by a high Child-Pugh score (especially Child-Pugh C), are at much higher risk.
• Low Ascitic Fluid Protein: As mentioned, ascitic fluid with protein levels below 1.5 g/dL is a major risk factor.
• Previous SBP Episode: Patients who have had SBP before have a substantially higher risk of recurrence.
• Gastrointestinal Bleeding: Episodes of variceal bleeding can trigger SBP, possibly due to increased bacterial translocation from the gut.
• Renal Impairment: Conditions like hepatorenal syndrome are associated with an increased risk.

Symptoms and Diagnosis

Symptoms of SBP can be nonspecific and may be mistaken for a worsening of the underlying liver disease. Common signs and symptoms include:

• Fever (often low-grade)
• Abdominal pain or tenderness
• Worsening ascites or abdominal distension
• Nausea and vomiting
• Diarrhea
• Hepatic encephalopathy (confusion, altered mental status)

Diagnosis is confirmed by paracentesis (sampling of ascitic fluid) and analysis. Key findings include an elevated ascitic fluid absolute neutrophil count (ANC) of 250 cells/mm³ or higher. Fluid culture can identify the causative organism, guiding antibiotic therapy.

Prevention and Management

Given the high morbidity and mortality associated with SBP, prevention and prompt treatment are crucial. Antibiotic prophylaxis is recommended for specific high-risk groups, such as patients with low ascitic fluid protein levels, those who have recovered from a previous SBP episode, and during episodes of gastrointestinal bleeding.